Literature DB >> 17320796

Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis.

Pascal Lapierre1, Kathie Béland, Fernando Alvarez.   

Abstract

Understanding the pathogenesis and progression of autoimmune hepatitis (AIH) at the molecular level could prove essential in developing new preventive and therapeutic strategies. Recently developed murine models have enabled the identification of various mechanisms involved in the development and perpetuation of this autoimmune disorder. Studies on these models have shown that a peripheral break of tolerance against liver-expressed antigens is sufficient to induce an autoimmune liver disease, which can occur without prior liver damage. Recent data have also shown that the liver selectively recruits and induces the apoptosis of activated CD8+ T cells after an immune response. This process of T-cell trapping involves the expression of specific chemokines and adhesion molecules, and these molecules are believed to play an important role in the initiation and perpetuation of autoimmune hepatitis. Hepatocyte apoptosis, induced by autoreactive T cells, follows specific pathways that could be targeted by new therapeutic agents. Basic research on the break of immune tolerance against liver antigens would be beneficial for patients with autoimmune hepatitis, as well as those suffering from other chronic inflammatory liver diseases, such as primary biliary cirrhosis and graft-versus-host diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17320796     DOI: 10.1016/j.trsl.2006.11.010

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  14 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

Review 3.  Autoimmune hepatitis in childhood: the role of genetic and immune factors.

Authors:  Priscila Menezes Ferri Liu; Débora Marques de Miranda; Eleonora Druve Tavares Fagundes; Alexandre Rodrigues Ferreira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

Review 4.  Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology.

Authors:  Julian Hercun; Catherine Vincent; Marc Bilodeau; Pascal Lapierre
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

Review 6.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

7.  Autoimmune hepatitis in a teenage boy: 'overlap' or 'outlier' syndrome--dilemma for internists.

Authors:  Arunansu Talukdar; Dibbendhu Khanra; Kabita Mukherjee; Manjari Saha
Journal:  BMJ Case Rep       Date:  2013-02-08

8.  Severe autoimmune hepatitis triggered by varicella zoster infection.

Authors:  Waleed K Al-Hamoudi
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

Review 9.  Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis.

Authors:  Pascal Lapierre; Alain Lamarre
Journal:  J Immunol Res       Date:  2015-05-28       Impact factor: 4.818

10.  Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.

Authors:  Hind I Fallatah; Hisham O Akbar
Journal:  Autoimmune Dis       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.